Janet Antwi, PhD
Senior Lecturer
Pharmacy Education and Innovation
Professional Interests
Dr. Antwi's expertise includes the design and synthesis of bioactive molecules for various diseases such as HIV-AIDs, cancer, and neglected tropical diseases. She teaches chemistry-related courses, including biochemistry and medicinal chemistry. She uses active learning techniques and promotes an environment where all students can be successful inside and outside the classroom.
Research Areas:
Biography
Dr. Janet Antwi obtained her Ph.D. in pharmaceutical sciences with a concentration in medicinal chemistry from The Ohio State University, College of Pharmacy, and holds a bachelor’s degree in chemistry from the State University of New York at Binghamton. Dr. Antwi is a trained medicinal chemist, and her expertise includes the design and synthesis of bioactive molecules for various diseases such as HIV-AIDs, cancer, and neglected tropical diseases. She teaches chemistry-related courses, including biochemistry and medicinal chemistry. She uses active learning techniques and promotes an environment where all students can be successful inside and outside the classroom.
Education
- 2017, PhD, The Ohio State University, College of Pharmacy, Medicinal Chemistry
- 2011, BA, State University of New York at Binghamton, Chemistry
Honors
- 2023, DEI Leadership Award Recipient
Publications
- Imidazoles as Potential Anticancer Agents: An Update on Recent Studies, Molecules. 2021 Jul | journal-article. doi: 10.3390/molecules26144213.
- Novel narrow spectrum benzyl thiophene sulfonamide derivatives to control Campylobacter, The Journal of Antibiotics. 2019 Jul | journal-article. doi: 10.1038/s41429-019-0168-x.
- A New Class of Allosteric HIV-1 Integrase Inhibitors Identified by Crystallographic Fragment Screening of the Catalytic Core Domain, Journal of Biological Chemistry. 2016 Nov | journal-article. doi: 10.1074/jbc.m116.753384.
- Indole-based allosteric inhibitors of HIV-1 integrase, Bioorganic & Medicinal Chemistry Letters. 2016 Oct | journal-article. doi: 10.1016/j.bmcl.2016.08.037.
- Novel Anti-Campylobacter Compounds Identified Using High Throughput Screening of a Pre-selected Enriched Small Molecules Library, Frontiers in Microbiology. 2016 Apr | journal-article. doi: 10.3389/fmicb.2016.00405.